The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global peripheral vascular devices market size reached US$ 10.13 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 15.51 Billion by 2027, exhibiting a growth rate (CAGR) of 7.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.
The increasing prevalence of venous diseases or CVI (chronic venous insufficiency) across the globe is creating a positive outlook for the market. Peripheral vascular devices provide sufficient blood flow to the brain, legs, and feet for proper functioning. Additionally, the rising geriatric population and the increasing incidences of various ailments, such as peripheral artery disease (PAD) and blockages, are favoring the market growth. Furthermore, this can be attributed to changing lifestyle habits, including smoking and high alcohol consumption, coupled with physical inactivity and unhealthy dietary habits. Apart from this, the growing inclination toward minimally invasive surgeries (MIS) due to fewer complications, less postoperative pain, shortened hospital stay, and faster recovery times are providing an impetus to the market growth. Moreover, the widespread adoption of atherectomy devices owing to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders is positively influencing the market growth. Other factors, including the significant growth in the healthcare industry, rising expenditure capacities of consumers, and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral vascular devices market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on device type and end user.
Breakup by Device Type:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, iVascular S.L.U., Koninklijke Philips N.V., Medtronic plc and Terumo Medical Corporation.
|Base Year of the Analysis||2021|
|Segment Coverage||Device Type, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, iVascular S.L.U., Koninklijke Philips N.V., Medtronic plc and Terumo Medical Corporation.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at